Ascletis Pharma Inc (2VJ) — Financial Flexibility Index
Ascletis Pharma Inc (2VJ) has a Financial Flexibility Index of -0.36x as of June 2023. Free cash flow of €-33.05 Million (operating CF €-33.98 Million minus capex €924.50K) represents 0% of total liabilities (€90.79 Million). Check 2VJ strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Ascletis Pharma Inc Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Ascletis Pharma Inc across 10 annual periods. See Ascletis Pharma Inc (2VJ) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Ascletis Pharma Inc (2016–2025)
Year-by-year free cash flow to debt coverage for Ascletis Pharma Inc. For the full company profile including market capitalisation, see Ascletis Pharma Inc stock valuation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.14x | €-414.80 Million | €-416.78 Million | €132.26 Million | ▼ -46.4% |
| 2024 | -2.14x | €-339.43 Million | €-341.58 Million | €158.41 Million | ▼ -56.0% |
| 2023 | -1.37x | €-204.64 Million | €-223.79 Million | €148.94 Million | ▼ -18.9% |
| 2022 | -1.16x | €-135.38 Million | €-142.45 Million | €117.16 Million | ▲ +17.9% |
| 2021 | -1.41x | €-141.96 Million | €-146.93 Million | €100.89 Million | ▼ -50.3% |
| 2020 | -0.94x | €-79.99 Million | €-84.91 Million | €85.42 Million | ▼ -72.5% |
| 2019 | -0.54x | €-55.46 Million | €-74.34 Million | €102.17 Million | ▲ +32.7% |
| 2018 | -0.81x | €-80.77 Million | €-96.59 Million | €100.19 Million | ▲ +46.4% |
| 2017 | -1.51x | €-182.76 Million | €-198.06 Million | €121.42 Million | ▼ -696.2% |
| 2016 | 0.25x | €32.11 Million | €-12.50 Million | €127.18 Million | — |